Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Acquisitions (Tables)

Note 3 - Acquisitions (Tables)

6 Months Ended

Dec. 31, 2016

Notes Tables

Business Acquisition, Pro Forma Information [Table Text Block]

		Quarter Ended								Six Months Ended
		December 31,								December 31,
		2016				2015				2016				2015
Net sales		$	131,807			$	127,008			$	263,605			$	244,698
Net income			30,170				26,918				50,161				49,470

Advanced Cell Diagnostics (ACD) [Member]

Notes Tables

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

		Preliminary Allocation at Acquisition Date				Adjustments to Fair Value				Updated Allocation at December 31, 2016
Current assets, net of cash		$	25,196							$	25,196
Equipment			2,757								2,757
Other long-term assets			3,812								3,812
Intangible assets:
Developed technology			107,000								107,000
Trade name			17,000								17,000
Customer relationships			77,000								77,000
Non-compete agreement			200								200
Goodwill			133,780				6,293				127,487
Total assets acquired			366,772								360,479
Liabilities			3,591								3,591
Deferred income taxes, net			78,761				(7,027	)			71,734
Net assets acquired		$	284,393							$	285,127

Cash paid, net of cash acquired		$	246,193				734			$	246,927
Fair value contingent consideration			38,200								38,200
Net assets acquired		$	284,393							$	285,127

Space [Member]

Notes Tables

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

		Space
Current assets, net of cash		$	2,128
Equipment			159
Intangible assets:
Customer relationships			6,769
Goodwill			3,100
Total assets acquired			12,156
Liabilities			1,884
Deferred income taxes, net			1,708
Net assets acquired		$	9,004

Cash paid, net of cash acquired		$	9,004